304 related articles for article (PubMed ID: 26216031)
1. Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study.
Achhra AC; Mocroft A; Reiss P; Sabin C; Ryom L; de Wit S; Smith CJ; d'Arminio Monforte A; Phillips A; Weber R; Lundgren J; Law MG;
HIV Med; 2016 Apr; 17(4):255-68. PubMed ID: 26216031
[TBL] [Abstract][Full Text] [Related]
2. Changes in body mass index and clinical outcomes after initiation of contemporary antiretroviral regimens.
Bannister WP; Mast TC; de Wit S; Gerstoft J; Wiese L; Milinkovic A; Hadziosmanovic V; Clarke A; Rasmussen LD; Lacombe K; Schommers P; Staub T; Zagalo A; Portu JJ; Tau L; Calmy A; Cavassini M; Gisinger M; Borodulina E; Mocroft A; Reekie J; Peters L;
AIDS; 2022 Dec; 36(15):2107-2119. PubMed ID: 35848573
[TBL] [Abstract][Full Text] [Related]
3. HIV-Infected Women Gain More Weight than HIV-Infected Men Following the Initiation of Antiretroviral Therapy.
Bares SH; Smeaton LM; Xu A; Godfrey C; McComsey GA
J Womens Health (Larchmt); 2018 Sep; 27(9):1162-1169. PubMed ID: 29608129
[TBL] [Abstract][Full Text] [Related]
4. Association of body mass index with immune recovery, virological failure and cardiovascular disease risk among people living with HIV.
Han WM; Jiamsakul A; Jantarapakde J; Yunihastuti E; Choi JY; Ditangco R; Chaiwarith R; Sun LP; Khusuwan S; Merati TP; Do CD; Azwa I; Lee MP; Van Nguyen K; Chan YJ; Kiertiburanakul S; Ng OT; Tanuma J; Pujari S; Zhang F; Gani YM; Sangle S; Ross J; Kumarasamy N;
HIV Med; 2021 Apr; 22(4):294-306. PubMed ID: 33200864
[TBL] [Abstract][Full Text] [Related]
5. HIV infection and obesity: where did all the wasting go?
Tate T; Willig AL; Willig JH; Raper JL; Moneyham L; Kempf MC; Saag MS; Mugavero MJ
Antivir Ther; 2012; 17(7):1281-9. PubMed ID: 22951353
[TBL] [Abstract][Full Text] [Related]
6. Body mass index and the risk of incident noncommunicable diseases after starting antiretroviral therapy.
Koethe JR; Jenkins CA; Turner M; Bebawy S; Shepherd BE; Wester CW; Sterling TR
HIV Med; 2015 Jan; 16(1):67-72. PubMed ID: 25230709
[TBL] [Abstract][Full Text] [Related]
7. Obesity, metabolic health and clinical outcomes after incident cardiovascular disease: A nationwide population-based cohort study.
Akyea RK; Ntaios G; Doehner W
J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2653-2662. PubMed ID: 37806948
[TBL] [Abstract][Full Text] [Related]
8. Impact of Integrase Inhibitors on Cardiovascular Disease Events in People With Human Immunodeficiency Virus Starting Antiretroviral Therapy.
Surial B; Chammartin F; Damas J; Calmy A; Haerry D; Stöckle M; Schmid P; Bernasconi E; Fux CA; Tarr PE; Günthard HF; Wandeler G; Rauch A;
Clin Infect Dis; 2023 Sep; 77(5):729-737. PubMed ID: 37157869
[TBL] [Abstract][Full Text] [Related]
9. Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and Canada.
Koethe JR; Jenkins CA; Lau B; Shepherd BE; Justice AC; Tate JP; Buchacz K; Napravnik S; Mayor AM; Horberg MA; Blashill AJ; Willig A; Wester CW; Silverberg MJ; Gill J; Thorne JE; Klein M; Eron JJ; Kitahata MM; Sterling TR; Moore RD;
AIDS Res Hum Retroviruses; 2016 Jan; 32(1):50-8. PubMed ID: 26352511
[TBL] [Abstract][Full Text] [Related]
10. Incidence of Diabetes Mellitus and Obesity and the Overlap of Comorbidities in HIV+ Hispanics Initiating Antiretroviral Therapy.
Gomes A; Reyes EV; Garduno LS; Rojas R; Mir Mesejo G; Del Rosario E; Jose L; Javier C; Vaughan C; Donastorg Y; Hammer S; Brudney K; Taylor BS
PLoS One; 2016; 11(8):e0160797. PubMed ID: 27508301
[TBL] [Abstract][Full Text] [Related]
11. Inflammation and Change in Body Weight With Antiretroviral Therapy Initiation in a Multinational Cohort of HIV-Infected Adults.
Mave V; Erlandson KM; Gupte N; Balagopal A; Asmuth DM; Campbell TB; Smeaton L; Kumarasamy N; Hakim J; Santos B; Riviere C; Hosseinipour MC; Sugandhavesa P; Infante R; Pillay S; Cardoso SW; Tripathy S; Mwelase N; Berendes S; Andrade BB; Thomas DL; Bollinger RC; Gupta A;
J Infect Dis; 2016 Jul; 214(1):65-72. PubMed ID: 26962236
[TBL] [Abstract][Full Text] [Related]
12. Weight change after antiretroviral therapy and mortality.
Yuh B; Tate J; Butt AA; Crothers K; Freiberg M; Leaf D; Logeais M; Rimland D; Rodriguez-Barradas MC; Ruser C; Justice AC
Clin Infect Dis; 2015 Jun; 60(12):1852-9. PubMed ID: 25761868
[TBL] [Abstract][Full Text] [Related]
13. Early mortality and cardiovascular disease, varied association with body mass index and its changes in insulin-treated diabetes: a nationwide study.
Lee YB; Kim B; Park J; Kim M; Choi MS; Kim G; Jin SM; Hur KY; Han K; Kim JH
Int J Obes (Lond); 2021 Nov; 45(11):2482-2489. PubMed ID: 34344992
[TBL] [Abstract][Full Text] [Related]
14. Effect of Changes in Body Mass Index on the Risk of Cardiovascular Disease and Diabetes Mellitus in HIV-Positive Individuals: Results From the D:A:D Study.
Petoumenos K; Kuwanda L; Ryom L; Mocroft A; Reiss P; De Wit S; Pradier C; Bonnet F; Phillips A; Hatleberg CI; d'Arminio Monforte A; Weber R; Sabin CA; Lundgren J; Law MG;
J Acquir Immune Defic Syndr; 2021 Apr; 86(5):579-586. PubMed ID: 33351531
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular risk prediction in HIV-infected patients: comparing the Framingham, atherosclerotic cardiovascular disease risk score (ASCVD), Systematic Coronary Risk Evaluation for the Netherlands (SCORE-NL) and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) risk prediction models.
Krikke M; Hoogeveen RC; Hoepelman AI; Visseren FL; Arends JE
HIV Med; 2016 Apr; 17(4):289-97. PubMed ID: 26268806
[TBL] [Abstract][Full Text] [Related]
16. Growth curve modelling to determine distinct BMI trajectory groups in HIV-positive adults on antiretroviral therapy in South Africa.
Brennan AT; Berry KM; Rosen S; Stokes A; Crowther NJ; George J; Raal F; Cassim N; Sanne I; Long L; Fox MP
AIDS; 2019 Nov; 33(13):2049-2059. PubMed ID: 31577571
[TBL] [Abstract][Full Text] [Related]
17. Obesity following ART initiation is common and influenced by both traditional and HIV-/ART-specific risk factors.
Bakal DR; Coelho LE; Luz PM; Clark JL; De Boni RB; Cardoso SW; Veloso VG; Lake JE; Grinsztejn B
J Antimicrob Chemother; 2018 Aug; 73(8):2177-2185. PubMed ID: 29722811
[TBL] [Abstract][Full Text] [Related]
18. Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.
Petoumenos K; Worm SW; Fontas E; Weber R; De Wit S; Bruyand M; Reiss P; El-Sadr W; Monforte AD; Friis-Møller N; Lundgren JD; Law MG;
J Int AIDS Soc; 2012 Oct; 15(2):17426. PubMed ID: 23078769
[TBL] [Abstract][Full Text] [Related]
19. Weight changes after antiretroviral therapy initiation in CoRIS (Spain): a prospective multicentre cohort study.
Martínez-Sanz J; Blanco JR; Muriel A; Pérez-Elías MJ; Rubio-Martín R; Berenguer J; Peraire J; Bernal E; Martínez OJ; Serrano-Villar S; Moreno S;
J Int AIDS Soc; 2021 May; 24(5):e25732. PubMed ID: 34036745
[TBL] [Abstract][Full Text] [Related]
20. Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment.
Capeau J; Bouteloup V; Katlama C; Bastard JP; Guiyedi V; Salmon-Ceron D; Protopopescu C; Leport C; Raffi F; Chêne G;
AIDS; 2012 Jan; 26(3):303-14. PubMed ID: 22089377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
